Hansa Biopharma — Februar 2024
-
Redeye RESEARCH NOTE 2024-02-02;
Hansa Biopharma: Confirms a record quarter for Idefirix:
-
-
Hansa Biopharma: Improved sales prospects (RESEARCH UPDATE
2024-02-05);
-
Fra debatten: https://www.proinvestor.com/boards/118516/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
ja kunne være rart de vil ud af døren på en gang så vil der for alvor ske noget med kursen 7,5% short lige nu